Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized Clinical Trial.

JAMA network open·2026
Same author

CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.

The New England journal of medicine·2026
Same author

Impact of co-amoxiclav versus amoxicillin on the gastrointestinal microbiota in sub-Saharan children hospitalized with pneumonia.

npj antimicrobials and resistance·2026
Same author

How to design a ROCI (Response Over Continuous Intervention) randomised trial: guidance and a case study.

BMC medical research methodology·2026
Same journal

Notice of Retraction. Ren Y, et al. Personality Traits and Social Isolation in Older Adults. JAMA Netw Open. 2026;9(5):e269569.

JAMA network open·2026
Same journal

Error in Grant Number in Funding/Support Section.

JAMA network open·2026
Same journal

The Supplementary Role of Friends in Caregiving Networks.

JAMA network open·2026
Same journal

Urbanicity, Neighborhood Conditions, and Dementia Mortality.

JAMA network open·2026
Same journal

Equity and Cancer Survival Among Veterans Health Administration Patients: A Systematic Review and Meta-Analysis.

JAMA network open·2026
Same journal

Limbic System Microstructure in Neonates With Antenatal Opioid Exposure.

JAMA network open·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

Multicenter Validation of Clinical Sepsis Phenotypes.

Chang Ho Yoon1,2, Daniel Sjöholm3, Kristin E Wickstrøm4,5,6

  • 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

JAMA Network Open
|June 1, 2026
PubMed
Summary
This summary is machine-generated.

The proposed sepsis clinical phenotypes from Sepsis Endotyping in Emergency Care (SENECA) data were not generalizable across three independent hospital cohorts. Further research is needed to identify sepsis subgroups using alternative methods.

More Related Videos

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Related Experiment Videos

Last Updated: Jun 2, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
14:45

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay

Published on: September 16, 2012

A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

Area of Science:

  • Critical Care Medicine
  • Data Science in Healthcare
  • Clinical Phenotyping

Background:

  • Electronic health records have enabled the proposal of four distinct clinical phenotypes for sepsis.
  • The generalizability and multisite validation of these sepsis phenotypes remain uncertain.
  • Accurate sepsis subtyping is crucial for targeted treatment and improved patient outcomes.

Purpose of the Study:

  • To validate the four clinical phenotypes derived from Sepsis Endotyping in Emergency Care (SENECA) data.
  • To assess the generalizability of SENECA sepsis phenotypes across multiple international healthcare settings.
  • To compare phenotypes derived at individual sites with the original SENECA phenotypes.

Main Methods:

  • A multisite retrospective cohort study involving adult patients from university hospitals in Stockholm, Oxford, and Oslo.
  • Inclusion criteria mandated body fluid cultures, antibiotic administration, and Sequential Organ Failure Assessment scores ≥2 within 6 hours of admission.
  • Consensus clustering with k-means was employed to derive and compare sepsis phenotypes across sites and with SENECA data.

Main Results:

  • Analysis included 30,865 (Stockholm), 15,575 (Oxford), and 1,806 (Oslo) patient encounters.
  • Low consistency was observed between SENECA phenotypes and site-specific phenotypes (Cohen κ: 0.32-0.40; Adjusted Rand Indices: 0.21-0.27).
  • Significant inconsistencies were also found between phenotypes derived from the three independent study sites.

Conclusions:

  • The four clinical phenotypes identified in the SENECA data lack generalizability across diverse European healthcare settings.
  • Current clustering methods may introduce stochasticity, limiting the reliability of derived sepsis phenotypes.
  • Alternative approaches are necessary to explore underlying sepsis heterogeneity and identify robust subgroups.